GH (STOCKS)
Guardant Health, Inc. Common Stock
$159.910000
-5.200000 (-3.15%)
Prev close: $165.110000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Helmy Eltoukhy
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $22,266.64M
- Employees
- 2,021
- P/E (TTM)
- -45.59
- P/B (TTM)
- -95.65
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
15
Strong Buy
17
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.42 | $-0.42 | -0.0001 | -0.02% |
|
Mar 2026 (Q1)
|
$-0.45 | $-0.51 | +0.0610 | +11.94% |
|
Dec 2025 (Q4)
|
$-1.00 | $-0.72 | -0.2783 | -38.56% |
|
Sep 2025 (Q3)
|
$-0.74 | $-0.72 | -0.0164 | -2.27% |
Financial Statements
| Revenues | $1.18B |
| Benefits Costs and Expenses | $1.64B |
| Cost Of Revenue | $413.95M |
| Costs And Expenses | $1.65B |
| Gross Profit | $769.16M |
| Operating Expenses | $1.24B |
| Research and Development | $375.79M |
| Other Operating Expenses | $863.63M |
| Operating Income/Loss | -$470.26M |
| Income/Loss From Continuing Operations After Tax | -$453.44M |
| Income/Loss From Continuing Operations Before Tax | -$454.47M |
| Income Tax Expense/Benefit | -$1.03M |
| Net Income/Loss | -$453.44M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$453.44M |
| Net Income/Loss Available To Common Stockholders, Basic | -$453.44M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.50 |
| Diluted Earnings Per Share | -$3.50 |
| Basic Average Shares | 265,521,000 |
| Diluted Average Shares | 265,521,000 |
| Assets | $1.91B |
| Current Assets | $1.36B |
| Inventory | $105.46M |
| Other Current Assets | $1.26B |
| Noncurrent Assets | $547.66M |
| Fixed Assets | $155.30M |
| Intangible Assets | $25.27M |
| Other Non-current Assets | $367.09M |
| Liabilities | $2.14B |
| Current Liabilities | $338.96M |
| Accounts Payable | $93.51M |
| Other Current Liabilities | $245.45M |
| Noncurrent Liabilities | $1.80B |
| Long-term Debt | $1.50B |
| Other Non-current Liabilities | $293.26M |
| Equity | -$222.87M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$222.87M |
| Liabilities And Equity | $1.91B |
| Net Cash Flow From Operating Activities | -$185.19M |
| Net Cash Flow From Operating Activities, Continuing | -$185.19M |
| Net Cash Flow From Investing Activities | -$118.53M |
| Net Cash Flow From Investing Activities, Continuing | -$118.53M |
| Net Cash Flow From Financing Activities | $737.80M |
| Net Cash Flow From Financing Activities, Continuing | $737.80M |
| Net Cash Flow | $431.77M |
| Net Cash Flow, Continuing | $434.08M |
| Comprehensive Income/Loss | -$455.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$455.28M |
| Other Comprehensive Income/Loss | -$1.84M |